Paul J. Bertics
9Patents
4h-index
9Co-inventors
46Inventor score
Filing activity: Oct 15, 1993 → Jul 15, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5492898A | Method of treating endotoxin effects with 2-methylthio-ATP and analogs | Chemistry; Metallurgy | 9 | Expired |
| US5624913A | Method reducing TNF-alpha in mammals with cerebral malaria | Emerging Cross-Sectional Technologies | 8 | Expired |
| US7795007B2 | Detection of post-translationally modified peptides with liquid crystals | Chemistry; Metallurgy | 6 | Active |
| US5516762A | Method of treating endotoxin effects with 2-haloadenosine nucleotide analogs | Chemistry; Metallurgy | 5 | Expired |
| US7560243B2 | White blood cell functional assay | Emerging Cross-Sectional Technologies | 1 | Expired |
| US6294694A | Matrix metalloproteinase inhibitors and method of using same | Chemistry; Metallurgy | 0 | Expired |
| US6531499B2 | Matrix metalloproteinase inhibitors and method of using same | Chemistry; Metallurgy | 0 | Expired |
| US7960131B2 | Functional genomic pore assay for mixed cell populations | Emerging Cross-Sectional Technologies | 0 | Active |
| US8569043B2 | Detection of post-translationally modified peptides with liquid crystals | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.